Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donor Regulatory T-cells for Steroid-Refractory cGVHD
NCT05095649Phase 2Recruiting
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Mar 2022
- Primary completion
- Aug 2025
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of regulatory T-cell enriched infusion in chronic graft-versus-host disease (cGVHD), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started Mar 2022; status: recruiting.
02
Drugs
regulatory T-cell enriched infusion
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT05095649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05095649.